Factors related to inhibition of lactation by pharmacological means at birth in a Spanish referral hospital (2011-2017)

Llupià, Anna; Torà, Isabel; Lladó, Alba; Cobo, Teresa; Sotoca, Josep Miquel; Puig, Joaquim.
Gac. sanit. (Barc., Ed. impr.) ; 36(1): 6-11, ene. - feb. 2022. tab
Artigo em Inglês | IBECS (Espanha) | ID: ibc-209160

Documentos relacionados

  1. Enfermedad de Cushing en el embarazo y uso de cabergolina.
  2. Assessing effects of dietary and milking frequency changes and injection of cabergoline during dry-off on hunger in dairy cows using 2 feed-thwarting tests.
  3. Use of dopamine agonists to target angiogenesis in women with endometriosis.
  4. Cabergoline for postpartum lactation suppression: Effect on blood pressure and pulse.
  5. Safety of Cabergoline for Postpartum Lactation Inhibition or Suppression: A Systematic Review.
  6. Effects of feed energy density, daily milking frequency, and a single injection of cabergoline on behavior and welfare in dairy cows at dry-off.
  7. Effects of feeding level, milking frequency, and single injection of cabergoline on feed intake, milk yield, milk leakage, and clinical udder characteristics during dry-off in dairy cows.
  8. Effect of the Prolactin Inhibitor Cabergoline and the Gonadotropin Releasing-Hormone Agonist Deslorelin in the Suppression of Plasma Prolactin Concentrations and Egg Laying in Quail (<i>Coturnix japonica</i>).
  9. The elusive role of prolactin in the sociality of the naked mole-rat.
  10. Comparing pyridoxine with dopaminergic agonists (cabergoline and bromocriptine): Unveiling the strategy for lactation inhibition - A systematic review of clinical trials.